These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 16904788

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH.
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [Abstract] [Full Text] [Related]

  • 3. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K, Targowski T, From S.
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
    Jacobson L, Hertzman P, Löfdahl CG, Skoogh BE, Lindgren B.
    Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
    Bilde L, Rud Svenning A, Dollerup J, Baekke Borgeskov H, Lange P.
    Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
    [Abstract] [Full Text] [Related]

  • 14. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes).
    Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF.
    Respir Med; 2008 Jan; 102(1):92-101. PubMed ID: 17881206
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M.
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [Abstract] [Full Text] [Related]

  • 19. Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore.
    Lee KH, Phua J, Lim TK.
    Respir Med; 2006 Dec; 100(12):2190-6. PubMed ID: 16635566
    [Abstract] [Full Text] [Related]

  • 20. Cost impact of COPD in Japan: opportunities and challenges?
    Nishimura S, Zaher C.
    Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.